Freedom Capital Markets Initiates Coverage On Inspire Medical Systems with Buy Rating, Announces Price Target of $62

Freedom Capital Markets analyst Keith Hinton initiates coverage on Inspire Medical Systems (NYSE: INSP ) with a Buy rating and announces Price Target of $62.